diabetes
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: (1) Age: 18-80 years old; (2) Patients who meet the diagnostic criteria of diabetes and are clinically classified as type 2 diabetes; According to the Chinese Guidelines for the Prevention and Treatment of Type 2 Diabetes (2020 Edition), patients with the following characteristics can be diagnosed with diabetes : ? Typical diabetes symptoms (including polydipsia, polydipsia, polyuria, polydipsia, weight loss); ? Random blood glucose =11.1mmol/L or fasting blood glucose =7.0mmol/L or OGTT2h blood glucose =11.1mmol/L or HbA1c=6.5%. Note: If there is no ? typical symptoms of diabetes, we need to check again on another day to confirm ?. (3) Agree and sign the informed consent.
Exclusion criteria
Exclusion criteria: (1) Type 1 diabetes mellitus or other special type diabetes mellitus; (2) Diabetic patients with acute complications of diabetes or poor blood glucose control: HbA1c > 9.5%; (3) Patients with severe chronic complications of diabetes (severe diabetic nephropathy, severe neuropathy, severe diabetic retinopathy, diabetic foot and lower limb artery occlusion); (4) Complicated with severe cardiovascular and cerebrovascular diseases, including myocardial infarction, congestive heart failure, severe arrhythmia, non-stable cerebrovascular accident, postural hypotension, etc.; (5) Unstable hypertension control =160/100mmHg; (6) Patients with other history of critical illness; Including severe liver disease, severe kidney disease, severe lung disease, lupus erythematosus, etc. (7) Life expectancy not more than 5 years (complicated with malignant tumor and poorly controlled disease); (8) Female subjects who are pregnant or plan to become pregnant within the next 12 weeks; (9) It is not expected to complete the intervention with other conditions; (10) Participated in other clinical trials within the last 4 weeks; (11) Unable to complete exercise or for other reasons, the researcher thinks it is not suitable to participate in this study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Glycosylated hemoglobin;Fasting blood glucose;Physical fitness assessment;TIR; | — |
Secondary
| Measure | Time frame |
|---|---|
| Imageological examination;blood lipids; | — |
Countries
China
Contacts
Yangpu Hospital Affiliated to Tongji University